Chip and MCR microarray analysis platform (IMAGE)
Caption
Based on the proven MCR microarray analysis platform of the Munich-based GWK Praezisionstechnik GmbH scientists at the Technical University of Munich have developed a new microarray-based rapid test for SARS-CoV-2 antibodies.
Credit
Sebastian Kissel / TUM
Usage Restrictions
Free for reporting on Technical University of Munich
License
Licensed content